BCI-215

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 525867

CAS#: 1245792-67-9

Description: BCI-215 is a hyperactivator of Fibroblast Growth Factor signaling, inducing rapid and sustained phosphorylation of ERK, p38, and JNK in the absence of reactive oxygen species, also hyperactivating MKK4/SEK1.


Price and Availability

Size
Price

Size
Price

Size
Price

BCI-215 is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 525867
Name: BCI-215
CAS#: 1245792-67-9
Chemical Formula: C22H22BrNO
Exact Mass: 395.0885
Molecular Weight: 396.328
Elemental Analysis: C, 66.67; H, 5.60; Br, 20.16; N, 3.53; O, 4.04


Synonym: BCI-215

IUPAC/Chemical Name: (E)-2-Benzylidene-5-bromo-3-cyclohexylamino-indan-1-one

InChi Key: JGWQWVVSCQBAFC-DEDYPNTBSA-N

InChi Code: InChI=1S/C22H22BrNO/c23-16-11-12-18-19(14-16)21(24-17-9-5-2-6-10-17)20(22(18)25)13-15-7-3-1-4-8-15/h1,3-4,7-8,11-14,17,21,24H,2,5-6,9-10H2/b20-13+

SMILES Code: O=C1/C(C(NC2CCCCC2)C3=C1C=CC(Br)=C3)=C/C4=CC=CC=C4


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


References

1: Kaltenmeier CT, Vollmer LL, Vernetti LA, Caprio L, Davis K, Korotchenko VN, Day BW, Tsang M, Hulkower KI, Lotze MT, Vogt A. A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity. J Pharmacol Exp Ther. 2017 Apr;361(1):39-50. doi: 10.1124/jpet.116.239756. Epub 2017 Feb 2. PubMed PMID: 28154014; PubMed Central PMCID: PMC5363763.